
Wellcome Trust appoints UK chief scientific adviser
pharmafile | July 3, 2012 | Appointment | Business Services, Manufacturing and Production, Research and Development, Sales and Marketing | UK government, Wellcome Trust
The director of the Wellcome Trust since 2003 Sir Mark Walport has been appointed to succeed Sir John Beddington as the UK government chief scientific adviser.
He will take up his new post in April 2013 and will step down as director early next year.
Walport said: “I am delighted and honoured to be appointed as the government chief scientific advisor. Science, engineering and technology have transformed the infrastructure of the modern world, and have a vital role to play at the heart of policy making.”
Sir Bill Castell, chairman of the Wellcome Trust, will lead the board of governors in the recruitment of a new director.
He said: “It is with great pleasure that I congratulate Sir Mark Walport on his appointment as the next government chief scientific adviser. Mark has led the Wellcome Trust with great distinction over a decade of extraordinary achievement, and there is nobody in Britain better placed to ensure that science plays the central role it deserves to in public policy. British science will be stronger for his appointment.”
Related Content

Moderna authorised to upscale development of mRNA vaccines in UK
Global researcher of mRNA medicine, Moderna, has been granted authorisation by the Medicines and Healthcare …

Valneva COVID-19 vaccine deal pulled by UK government
Boris Johnson and the UK government have terminated its deal with specialist vaccine company Valneva …

World’s first COVID-19 vaccine booster study launches in UK
The UK government has announced that thousands of volunteers will receive a booster COVID-19 vaccine …






